Reducing Central Line Associated Bloodstream Infections (CLABSIs) by Reducing Central Line Days.

Central line associated bloodstream infections Central line days Infection prevention Midline catheters

Journal

Current infectious disease reports
ISSN: 1523-3847
Titre abrégé: Curr Infect Dis Rep
Pays: United States
ID NLM: 100888983

Informations de publication

Date de publication:
2021
Historique:
accepted: 17 09 2021
entrez: 8 11 2021
pubmed: 9 11 2021
medline: 9 11 2021
Statut: ppublish

Résumé

While reducing unnecessary days present of central venous catheters (CVCs) is part of central line associated bloodstream infection (CLABSI) best practices, there is limited information regarding compliance with this recommendation as well as addressing barriers to compliance. Significant work has been directed towards daily audits of necessity and improving communication between members of the medical team. Other critical interventions include utilization of the electronic health record (EHR), leadership support of CLABSI reduction goals, and avoiding CVC placement over more appropriate vascular access. Institutions have varied approaches to addressing the issue of removing idle CVCs, and more standardized approaches in checklists as well as communication, particularly on multidisciplinary rounds, will be key to CVC removal. Utilization of the EHR for reminders or appropriate documentation of necessity is a factor. Avoidance of placing a CVC or appropriateness of the CVC is also important to consider.

Identifiants

pubmed: 34744517
doi: 10.1007/s11908-021-00767-w
pii: 767
pmc: PMC8562022
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

23

Informations de copyright

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.

Déclaration de conflit d'intérêts

Conflict of InterestASMB, DH, GV, and PB all declare no conflicts of interest.

Références

Am J Infect Control. 2018 Jul;46(7):788-792
pubmed: 29525366
Can J Anaesth. 2012 Dec;59(12):1102-10
pubmed: 23055033
Infect Control Hosp Epidemiol. 2011 Feb;32(2):101-14
pubmed: 21460463
Infect Control Hosp Epidemiol. 2012 Jan;33(1):50-7
pubmed: 22173522
J Surg Res. 2014 Sep;191(1):1-5
pubmed: 24565504
Infect Control Hosp Epidemiol. 2021 Feb;42(2):222-224
pubmed: 32972464
J Emerg Med. 2016 Sep;51(3):252-8
pubmed: 27397766
Am J Infect Control. 2014 Oct;42(10 Suppl):S197-202
pubmed: 25239710
J Hosp Infect. 2011 Apr;77(4):304-8
pubmed: 21288595
JAMA Intern Med. 2013 Dec 9-23;173(22):2039-46
pubmed: 23999949
Medicine (Baltimore). 2018 Oct;97(42):e12782
pubmed: 30334966
Jt Comm J Qual Patient Saf. 2018 Oct;44(10):590-598
pubmed: 30064951
Intensive Crit Care Nurs. 2021 Apr;63:102974
pubmed: 33262010
Pediatrics. 2013 Jun;131(6):e1961-9
pubmed: 23690523
Am J Infect Control. 2016 Dec 1;44(12):1458-1461
pubmed: 27908432
Ann Intern Med. 2015 Sep 15;163(6 Suppl):S1-40
pubmed: 26369828
Comput Inform Nurs. 2020 Nov 2;39(4):208-214
pubmed: 33136611
Am J Infect Control. 2013 Feb;41(2):107-12
pubmed: 22980513
J Infect Prev. 2020 Nov;21(6):228-233
pubmed: 33408760
Crit Care Med. 2021 Feb 1;49(2):e140-e150
pubmed: 33372744
Ann Intern Med. 2014 Oct 21;161(8):562-7
pubmed: 25329204
Pediatrics. 2015 Jun;135(6):e1485-93
pubmed: 25986020
Am J Infect Control. 2014 Apr;42(4):453-5
pubmed: 24679577
Infect Control Hosp Epidemiol. 2018 Dec;39(12):1442-1448
pubmed: 30305194
J Hosp Med. 2016 Apr;11(4):269-75
pubmed: 26717423
Jt Comm J Qual Patient Saf. 2020 Feb;46(2):99-108
pubmed: 31879072
Infect Control Hosp Epidemiol. 2003 Dec;24(12):942-5
pubmed: 14700410
Am J Crit Care. 2019 Jul;28(4):290-298
pubmed: 31263012
BMJ Qual Saf. 2019 Sep;28(9):714-720
pubmed: 30886119
Infect Control Hosp Epidemiol. 2014 Sep;35 Suppl 2:S89-107
pubmed: 25376071
Infect Control Hosp Epidemiol. 2019 Jun;40(6):674-680
pubmed: 30924436
Ther Clin Risk Manag. 2018 Aug 21;14:1453-1456
pubmed: 30174427
Infect Control Hosp Epidemiol. 2010 Nov;31(11):1101-5
pubmed: 20929300
Int J Infect Dis. 2019 Jul;84:22-29
pubmed: 31005622
Am J Infect Control. 2018 Feb;46(2):229-231
pubmed: 29031430
Am J Infect Control. 2019 Sep;47(9):1118-1121
pubmed: 31047692

Auteurs

Amber Shaye McElveen Beville (ASM)

Prisma Health-Midlands, Columbia, South Carolina USA.

Diane Heipel (D)

Virginia Commonwealth University Health System, Richmond, VA USA.

Ginger Vanhoozer (G)

Virginia Commonwealth University Health System, Richmond, VA USA.

Pamela Bailey (P)

Prisma Health-Midlands, Columbia, South Carolina USA.
University of South Carolina School of Medicine, Columbia, SC USA.

Classifications MeSH